HARC 018 - An Open Label Pilot Study of the Safety and
Tolerance of Slow-Release Niacin for the Treatment of Protease Inhibitor
Associated Hypertriglyceridemia. This
study being developed by our pharmacist, Dr. Scott Souza, and our new
co-investigator with the Hawaii ACTU, Dr. Dominic Chow, will look at the safety
and tolerance of niacin when used for hypertriglyceridemia due to protease
inhibitor use. There are concerns
regarding interaction with various anti-retroviral medications which will be
looked at. In addition, the extent
of efficacy of niacin in the context of treatment for HIV-1 infection will be
investigated.